of December 31, 2019, by a significant increase which is a result of the implementation of TFRS 16 2.2 Liabilities As of March 31, 2020, the Group had total liabilities of Bt12,564. 7 million
, the stated TFRS was adjusted in order for the contents to be equivalent to the International Financial Reporting Standard (IFRS). The significant changes are summarized as follows: 2.1 TFRS 9 Financial
period of 2020 was 29.62 million Baht or 18.58% of total revenue. The net profit decrease by 2.75 million Baht or down by 8.50% from the same period last year. This was due to a significant decrease in
%, compared with the same period of the last year. As a result of operating profit that significant growth and finance costs are very low level because of the stable financial position. DOD BIOTECH PUBLIC
., BANGKAE, BANGKAE, BANGKOK, THAILAND. 10160 Tel: 02-455-2888 Fax: 02-455-2763 (“TRANSLATION”) TG 145/2562 November 11, 2019 Subject: Clarification of the Operating Result for the significant change Attention
ดิง ชัน 20 ซอยสุขุมวิท 55 ถนนสุขุมวิท แขวงคลองตนัเหนือ เขตวฒันา กรุงเทพมหานคร 10110 Expenses Selling expenses Selling expenses was 290.4 MB, an increased by 82.8 MB or 39.9% y-o-y, significant increase
1,375 million Baht. The significant increase was mainly due to the ability to continually transfer of The Ritz-Carlton Residences, Bangkok at MahaNakhon totaling of 94 residences, and to recognize revenue
addition, the said transaction is considered as a disposal of asset, notwithstanding, does not belong to a disposal of significant asset of listed company. 7. Rationale and necessity of the transaction
total revenue. The net profit increased by 318.11 million Baht or 239.32% from the same period last year. The significant increase in revenue is the result of ownership transfer. Please be informed
to the net profit of Baht 21.99 million in the Quarter 3/2018. Our book value per share as at 30 September 2019 stood at 60.01 Baht. (as at 30 September 2018 : at 32.80 Baht) Significant changing is as